Published in Brain on January 01, 2003
CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol (2010) 1.88
α-Adrenergic vasoconstrictor responsiveness is preserved in the heated human leg. J Physiol (2010) 1.17
Nitric oxide-related drug targets in headache. Neurotherapeutics (2010) 1.07
Migraine: where and how does the pain originate? Exp Brain Res (2009) 1.06
Migraine pain: reflections against vasodilatation. J Headache Pain (2009) 0.94
Headache-type adverse effects of NO donors: vasodilation and beyond. Br J Pharmacol (2010) 0.88
Characterization of a novel model of chronic migraine. Pain (2013) 0.87
Main anatomical features of the M1 segment of the middle cerebral artery: a 3D time-of-flight magnetic resonance angiography at 3 T study. Surg Radiol Anat (2008) 0.87
Serotonin and CGRP in migraine. Ann Neurosci (2012) 0.86
Cyclic AMP Accumulation in Migraine Induction. Pediatr Neurol Briefs (2015) 0.86
Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J Headache Pain (2014) 0.85
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. J Headache Pain (2008) 0.82
Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience (2016) 0.80
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate. J Headache Pain (2008) 0.77
Effect of a phosphodiesterase 5 inhibitor on pulmonary and cerebral arteries of newborn piglets with chronic hypoxia-induced pulmonary hypertension. Neonatology (2011) 0.77
Author's reply on Pathophysiology of migraine. Ann Indian Acad Neurol (2013) 0.75
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A. PLoS One (2014) 0.75
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Cost of disorders of the brain in Europe. Eur J Neurol (2005) 6.41
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol (2013) 3.87
Evidence for a vascular factor in migraine. Ann Neurol (2011) 2.93
Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia (2013) 2.87
Provocation of migraine with aura using natural trigger factors. Neurology (2013) 2.39
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet (2010) 2.35
Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology (2006) 2.28
PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain (2008) 2.17
Vestibular migraine: diagnostic criteria. J Vestib Res (2012) 2.04
Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology (2003) 1.99
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia (2010) 1.88
Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia (2010) 1.65
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain (2014) 1.52
Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol (2009) 1.51
Consensus document on European brain research. Eur J Neurosci (2011) 1.45
On the methodology of drug trials in migraine with aura. Cephalalgia (2010) 1.45
[Clinical symptoms and pathophysiology of migraine]. Ugeskr Laeger (2008) 1.40
BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther (2005) 1.34
No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol (2005) 1.25
ICHD-3 beta is published. Use it immediately. Cephalalgia (2013) 1.20
Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. J Headache Pain (2011) 1.14
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther (2009) 1.13
Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology (2006) 1.08
Trigeminal neuralgia--a prospective systematic study of clinical characteristics in 158 patients. Headache (2014) 1.06
Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache (2002) 1.03
Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain (2012) 1.02
Characterization of consistent triggers of migraine with aura. Cephalalgia (2010) 1.01
Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur J Pain (2003) 0.99
Chronic migraine--classification, characteristics and treatment. Nat Rev Neurol (2012) 0.99
Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia (2010) 0.94
The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab (2002) 0.93
Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues. Biochim Biophys Acta (2008) 0.93
New plans for headache classification: ICHD-3. Cephalalgia (2010) 0.92
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol (2004) 0.92
Effect of two novel CGRP-binding compounds in a closed cranial window rat model. Eur J Pharmacol (2007) 0.92
Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine. Headache (2011) 0.92
Nitric oxide synthase (NOS) in the trigeminal vascular system and other brain structures related to pain in rats. Neurosci Lett (2010) 0.90
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia (2011) 0.89
Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia (2012) 0.89
Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation. Cephalalgia (2013) 0.89
Possible site of action of CGRP antagonists in migraine. Cephalalgia (2011) 0.87
A naturalistic glyceryl trinitrate infusion migraine model in the rat. Cephalalgia (2011) 0.86
Interhemispheric differences of fMRI responses to visual stimuli in patients with side-fixed migraine aura. Hum Brain Mapp (2013) 0.86
Implications of clinical subtypes of migraine with aura. Headache (2006) 0.86
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia (2012) 0.86
Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype. Neurology (2008) 0.86
Multitracer test approach to characterize reactive transport in karst aquifers. Ground Water (2007) 0.86
Antimigraine efficacy of telcagepant based on patient's historical triptan response. Headache (2010) 0.85
Migraine before rupture of intracranial aneurysms. J Headache Pain (2013) 0.85
The in vivo effect of adrenomedullin on rat dural and pial arteries. Eur J Pharmacol (2006) 0.85
Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues. Eur J Pharmacol (2010) 0.85
Sources of variability of resting cerebral blood flow in healthy subjects: a study using ¹³³Xe SPECT measurements. J Cereb Blood Flow Metab (2013) 0.84
Genome-wide association study identifies four loci associated with eruption of permanent teeth. PLoS Genet (2011) 0.84
Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience. Cephalalgia (2013) 0.84
The future of headache classification and classification research. Cephalalgia (2009) 0.83
The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab (2004) 0.83
Prostaglandins in migraine: update. Curr Opin Neurol (2013) 0.83
Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study. BMJ Open (2012) 0.82
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept (2007) 0.82
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. J Headache Pain (2008) 0.82
Concomitant persistent pain in classical trigeminal neuralgia--evidence for different subtypes. Headache (2014) 0.82
Future possibilities in migraine genetics. J Headache Pain (2012) 0.82
Licence for Botox in so-called chronic migraine. Lancet (2010) 0.81
Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system. Neurosci Lett (2006) 0.81
Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Eur J Pharmacol (2004) 0.81
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials. J Headache Pain (2012) 0.81
[Keep the PhD degree, but eliminate the thesis]. Ugeskr Laeger (2013) 0.81
Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP. J Headache Pain (2010) 0.81
Taking the negative view of current migraine treatments: the unmet needs. CNS Drugs (2012) 0.81
Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects. Cephalalgia (2011) 0.81
The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers. Cephalalgia (2013) 0.81
Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain (2008) 0.81
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models. Cephalalgia (2012) 0.80
The Yekaterinburg headache initiative: an interventional project, within the Global Campaign against Headache, to reduce the burden of headache in Russia. J Headache Pain (2013) 0.80
The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am J Med Genet B Neuropsychiatr Genet (2006) 0.80
Quantitative sensory testing in classical trigeminal neuralgia-a blinded study in patients with and without concomitant persistent pain. Pain (2016) 0.79
No release of interstitial glutamate in experimental human model of muscle pain. Eur J Pain (2005) 0.79
Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man. Cephalalgia (2011) 0.79
Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. Eur J Pharmacol (2011) 0.79
Pharmacological and molecular comparison of K(ATP) channels in rat basilar and middle cerebral arteries. Eur J Pharmacol (2006) 0.79
The PACAP receptor: a novel target for migraine treatment. Neurotherapeutics (2010) 0.79
The relative influence of environment and genes in episodic tension-type headache. Neurology (2004) 0.79
5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks. Cephalalgia (2010) 0.79
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia (2010) 0.79
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D₂ (PGD₂). Cephalalgia (2010) 0.78
PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system. Brain Res (2009) 0.78
Towards a better understanding of the size and burden and cost of brain disorders in Europe. Eur Neuropsychopharmacol (2005) 0.78
Neuronal fast activating and meningeal silent modulatory BK channel splice variants cloned from rat. Pflugers Arch (2010) 0.78
Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat. Headache (2008) 0.78
Coexisting typical migraine in familial hemiplegic migraine. Neurology (2010) 0.78
Pharmacological and expression profile of the prostaglandin I(2) receptor in the rat craniovascular system. Vascul Pharmacol (2011) 0.78